
Retatrutide
Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.
ELVORA · RESEARCH PEPTIDES
Discover the Elvora catalogue with clearly organised product information and a calm, factual product selection.
Bestsellers
Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.
View productResearch sources
Bestsellers

Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.

BPC-157 is a synthetic pentadecapeptide studied in preclinical tissue and repair research.

Tirzepatide is a dual GIP and GLP-1 receptor agonist.

TB-500 commonly denotes Ac-LKKTETQ, an acetylated fragment of thymosin β4.
Research context
Elvora organises catalogue information for an intended laboratory research context. The content contains no medical recommendations, makes no claim of regulatory approval and is not a substitute for legal review.
Learn moreBefore ordering
They are intended solely for the specified laboratory research context. They are not intended for use in humans or animals, and the information does not constitute medical advice.
Each product page shows available options, prices and its assigned warehouse. Technical details and documents appear only when they have been verified.
Verified batch-specific files appear for eligible EU Warehouse products and in the certificates overview. If no document is available, no download or testing claim is shown.
Filter the catalogue by warehouse, open the product page and compare the available options, prices and documents before adding an item to the cart.